PITTSBURGH, Jan. 7 /PRNewswire/ -- Cohera Medical, Inc., a rapidly
growing medical device company developing a suite of wound management
systems and surgical adhesives, announced today that it has expanded its
executive management team with the appointment of Chad Coberly as Vice
President of Clinical, Regulatory and Legal Affairs. Mr. Coberly has more
than 15 years of experience in the medical device industry, primarily in
the areas of regulatory/clinical affairs, compliance, quality systems,
intellectual property, business development, litigation and general legal
affairs. He brings experience from the law firm of Howard and Howard, the
Surgical Group of the Stryker Corporation, and most recently Zassi Medical
Evolutions where he served as the Vice President of Legal and Regulatory
"Chad brings extensive domain-specific knowledge and industry
experience to our company," said Mr. Patrick Daly, President and CEO of
Cohera Medical. "In addition to his regulatory expertise, he has published
articles in Food and Drug Law Institute publications and has held
board-level positions with Medical Device Associations. We are fortunate to
have him as a member of our growing team."
Mr. Coberly holds a J.D. from Michigan State University and a
bachelor's degree in biomedical engineering from Tulane University. He also
has completed MBA studies at Boston University. He is admitted to practice
before the U.S. Patent and Trademark Office and is a member of the Michigan
Cohera has also formalized its Clinical Advisory Board, which includes
the following world renowned surgeons and scientists:
-- Peter Rubin, MD is the Founder and Director of the Life After Weight
Loss surgical body contouring program at the University of Pittsburgh,
and author of "Aesthetic Plastic Surgery After Massive Weight Loss." He
is the recipient of the Presidential Early Career Award for Scientists
and Engineers, the highest honor bestowed upon young scientists by the
United States government.
-- Russell F. Warren, MD is the Surgeon-in-Chief Emeritus of the Hospital
for Special Surgery (HSS) in Manhattan and Professor of Orthopedics at
the Weill Medical College of Cornell University. He is currently the
Team Physician for the New York Giants.
-- Richard M. Green, MD, FACS is currently chairman, Department of
Surgery, at Lenox Hill Hospital, in New York City. In 2005, he also
became co-director, Division of Peripheral and Vascular Intervention at
Lenox Hill Hospital.
-- Michael Buckley, MD is co-founder of Cohera Medical and co-inventor of
the company's core technology. He is an oral and maxillofacial surgeon
in private practice. Dr. Buckley serves as the national Treasurer of
the American Cleft Palate-Craniofacial Association.
"Cohera has attracted quite a prestigious group of advisors to provide
expert feedback on our efforts in new product development," said Mr. Daly.
"We look forward to working with them to create products that will continue
to revolutionize the practice of surgery in all disciplines."
About Cohera Medical, Inc.
Cohera Medical, Inc. is developing a revolutionary line of wound
management products and surgical adhesives. Our products are based on a
unique chemical design that is purely synthetic, easy to use, biocompatible
and fully resorbable. Our lead product in development, TissuGlu(TM) Wound
Management System, is a sprayable bonding agent for plastic surgery
procedures. TissuGlu(TM) adheres flaps of tissue after surgical procedures,
eliminating the spaces where fluid accumulates and reducing wound drainage.
Pre-clinical testing has shown that TissuGlu(TM) virtually eliminates
seroma formation, one of the most common complications of abdominoplasty
procedures. Cohera is also developing additional surgical adhesives
targeting mesh fixation and small bone fixation, which will fill similar
market needs in both orthopedics and general surgery. TissuGlu(TM) and the
other Cohera products have not yet been approved for medical use by the
Food and Drug Administration (FDA) in the US or by any other country's
SOURCE Cohera Medical, Inc.